TE_38973
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR19B |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | TTTY14 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.39 |
| Counts of samples | TCGA_tumor:399; TCGA_normal:54; GTEx:1102 |
| TSS | chrY(-):18840148 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38973.1 | TTTY14 | Annoated | Non-coding | Non-coding | chrY(-):18804827,18804847,18813616,18813743,18819355,18819460,18819554,18819786,18828585,18828719,18830436,18830639,18833002,18833103,18833756,18833918,18836320,18836409,18839182,18839313,18839932,18840149 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
